
|Videos|October 12, 2021
Dr. Lee discusses potential of Moses-augmented HoLEP treatment
Author(s)Urology Times staff
“This study was very important in that it showed cost savings with MOSES as well as the ability to reliably achieve same-day discharge,” says Matthew S. Lee, MD.
Advertisement
In this video Matthew S. Lee, MD,discusses the patient selection process and takeaways of the Urology Practice study, “A cost comparison of holmium laser enucleation of the prostate with and without Moses.” Lee is an endourology fellow at Northwestern University, Evanston, Illinois.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Testosterone deficiency: FAQs from the AUA guideline
3
Joshua Lang, MD, MS, on integrating molecular biomarkers into clinical practice
4
Large registry study reports durable 10-year outcomes with focal therapy for prostate cancer
5












